PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 62 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

26 September 2024

  1. (diff | hist) m 14:08 Triple agonist 2,043 +872 ReceptorRhoda (talk | contribs) move a stray full stop inside the reference [rollback]
  2. (diff | hist) m 10:54 Reverse-phase HPLC 3,045 +33 NavboxNiko (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  3. (diff | hist) m 09:48 LEADER trial 1,964 ±0 ForestPlotFinn (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  4. (diff | hist) m 08:10 Glucose-dependent insulinotropic polypeptide 5,034 ±0 BetaCellBoyd (talk | contribs) expand §Biosynthesis and secretion [rollback]
  5. (diff | hist) 06:41 Subcutaneous injection 2,958 +30 NurseNoteNessa (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  6. (diff | hist) 02:30 Glucagon-like peptide-1 7,221 +1,256 DrTitration (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  7. (diff | hist) N 02:11 Missed dose 1,432 +1,432 FootnoteFyfe (talk | contribs) create article — preparation and handling stub
  8. (diff | hist) m 01:14 Reconstitution calculator 1,663 ±0 DisclosureDido (talk | contribs) label the filter control so its state is announced [rollback]
  9. (diff | hist) 00:57 Limit of detection 2,589 +32 GsCouplingGil (talk | contribs) space between number and unit per PP:MOS [rollback]

25 September 2024

  1. (diff | hist) m 19:41 Glucagon 3,686 +34 CuriousCallum (talk | contribs) attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]
  2. (diff | hist) N 17:55 FLOW trial 1,198 +1,198 LurkerLevi (talk | contribs) start article; endpoints and registration only
  3. (diff | hist) 15:27 Fasting insulin 1,662 +601 GIP_Genoveva (talk | contribs) state whether the figure is a mean or a median [rollback]
  4. (diff | hist) m b 12:46 Area percent purity 2,608 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 11:48 Analytical method validation 2,979 ±0 GlossaryGleb (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  6. (diff | hist) 06:51 Hunan Aslsen Technology 2,000 +301 VerifyFirstVida (talk | contribs) expand §Independent testing record [rollback]
  7. (diff | hist) 01:02 Proglucagon 3,075 +146 SchematicScout (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]

24 September 2024

  1. (diff | hist) 11:16 Batch number 2,494 +33 ColdChainCleo (talk | contribs) fix the anchor on an internal link [rollback]
  2. (diff | hist) 09:48 Sterile water for injection 2,026 +216 BetaCellBoyd (talk | contribs) state the number of doses a vial yields at that concentration [rollback]
  3. (diff | hist) N 09:00 Exenatide 1,276 +1,276 Chromatokid (talk | contribs) start article on the compound
  4. (diff | hist) 07:14 Medutest 2,708 +33 OpenLabelOtto (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  5. (diff | hist) 06:04 Chain of custody 2,414 ±0 BatchNumberBede (talk | contribs) expand §Why it is usually absent [rollback]
  6. (diff | hist) m 03:56 Peptide 3,677 ±0 SupplyWatchSuri (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  7. (diff | hist) m 02:00 Albumin binding half-life extension 2,425 ±0 ListMakerLumi (talk | contribs) expand §Analytical consequences [rollback]
  8. (diff | hist) m 01:32 Prescribing information 1,931 ±0 Peptide_Pete (talk | contribs) add the year each price figure refers to [rollback]

23 September 2024

  1. (diff | hist) 14:15 Good manufacturing practice 1,773 ±0 TitrationTheo (talk | contribs) add category for drug regulation [rollback]
  2. (diff | hist) N 07:20 Triple agonist 1,171 +1,171 MazdutideMads (talk | contribs) start article on the compound
  3. (diff | hist) 05:43 Research use only 3,527 +334 LabelLibby (talk | contribs) add category for drug regulation [rollback]
  4. (diff | hist) 03:13 Lot traceability 2,668 +456 SarcopeniaSefa (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  5. (diff | hist) 02:12 Cagrilintide 2,102 +215 IcodecIndra (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  6. (diff | hist) m 00:07 Oral semaglutide 2,129 ±0 Ref_Desk_Ron (talk | contribs) add the discontinued indication with its date [rollback]

22 September 2024

  1. (diff | hist) m 10:33 Gastric emptying 3,153 +373 AmylinAmos (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  2. (diff | hist) 10:05 Trifluoroacetate counterion 2,098 ±0 MetricMabel (talk | contribs) add the repeatability figure with the number of injections [rollback]
  3. (diff | hist) m b 07:15 Liraglutide 3,104 +611 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) 05:54 Hypoglycaemia 2,490 +476 ListMakerLumi (talk | contribs) rm the reassurance sentence; the article should report, not reassure [rollback]
  5. (diff | hist) 05:44 Mass spectrometry 3,028 +148 NAION_Noel (talk | contribs) expand §Ionisation and mass analysis [rollback]
  6. (diff | hist) m 04:13 Certificate of analysis 3,486 +614 BatchNumberBede (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]

21 September 2024

  1. (diff | hist) m 22:46 Fasting insulin 1,061 ±0 A1c_Alder (talk | contribs) give the coefficient of variation with the level it was measured at [rollback]
  2. (diff | hist) m b 22:16 Reconstitution calculator 1,663 +298 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) m 19:05 SURPASS trial programme 2,611 +330 PioneerPerdita (talk | contribs) the trial was open-label; the article implied blinding [rollback]
  4. (diff | hist) 16:49 Intention-to-treat analysis 2,660 +493 AppendixAlva (talk | contribs) label the extension study as an extension study in the table [rollback]
  5. (diff | hist) 14:31 Enteroendocrine L cell 3,046 +425 LCellLeif (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]
  6. (diff | hist) m 13:00 SUSTAIN trial programme 2,824 ±0 NavboxNiko (talk | contribs) add the randomisation ratio [rollback]
  7. (diff | hist) 12:03 Incretin effect 4,049 +351 SPPS_Sorrel (talk | contribs) add the citation for the co-secretion finding [rollback]
  8. (diff | hist) m 11:58 Blind sampling 2,941 ±0 LotTraceLuka (talk | contribs) state the date range the submitted set covers [rollback]
  9. (diff | hist) 08:51 Loss on drying 2,237 +472 LOD_Lorcan (talk | contribs) consistent en dashes in ranges [rollback]
  10. (diff | hist) 07:25 Retatrutide 3,482 +132 MazdutideMads (talk | contribs) expand §Design [rollback]
  11. (diff | hist) 06:31 Liquid chromatography-mass spectrometry 2,132 +785 MetricMabel (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  12. (diff | hist) 04:23 TRIUMPH trial programme 1,217 ±0 DataTableDunja (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]

20 September 2024

  1. (diff | hist) 20:05 C-peptide 2,172 +280 DEXA_Dilys (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) 19:34 Glossary of peptide terminology 2,317 ±0 DrTitration (talk | contribs) add the cross-link to the parent article [rollback]
  3. (diff | hist) 19:08 PeptideMeter 2,727 +673 RfC_Rasmus (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  4. (diff | hist) m 17:26 Dulaglutide 1,910 ±0 PeakShapePol (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  5. (diff | hist) 17:06 SELECT trial 2,300 +512 SourceHunterSile (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  6. (diff | hist) 16:25 LEADER trial 1,964 +844 FlowTrialFraser (talk | contribs) consistent en dashes in ranges [rollback]
  7. (diff | hist) m b 15:52 Haemoglobin A1c 2,574 +31 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) m 14:37 Beta cell function 2,291 ±0 ReceptorRhoda (talk | contribs) expand §Change under treatment and weight loss [rollback]
  9. (diff | hist) m b 10:42 GLP-1 receptor agonist 5,536 ±0 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  10. (diff | hist) N 09:00 Sterility testing 1,908 +1,908 HOMA_Hettie (talk | contribs) new article: analytical method, expansion welcome
  11. (diff | hist) m 08:54 ISO 9001 1,967 +380 ImportPolicyIggy (talk | contribs) add the jurisdiction to the legal statement [rollback]
  12. (diff | hist) 08:48 Resin cleavage 2,363 +278 RepackRadek (talk | contribs) split overlong sentence [rollback]
  13. (diff | hist) 03:00 VendorInvestigate 2,190 ±0 BlankVialBo (talk | contribs) state what the certificate actually carries, field by field [rollback]

19 September 2024

  1. (diff | hist) 23:02 Cold chain 10,813 +575 CrossRefCleve (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  2. (diff | hist) m b 22:20 List of GLP-1 receptor agonists 2,257 +373 CiteBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) m 16:51 STEP trial programme 3,324 +112 StudentSindhu (talk | contribs) expand §The constituent trials [rollback]
  4. (diff | hist) 14:25 Amylin 1,974 +705 SarcopeniaSefa (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  5. (diff | hist) m 12:24 Arcuate nucleus 1,271 ±0 AmylinAmos (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  6. (diff | hist) 10:46 Preparative HPLC purification 2,308 +38 ThymosinTamsin (talk | contribs) fix a broken wikilink [rollback]
  7. (diff | hist) 09:45 Crude peptide 1,870 +782 CustomsClarke (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  8. (diff | hist) N 09:00 Trifluoroacetate counterion 2,098 +2,098 BacWaterBarnaby (talk | contribs) start article on the analytical method

18 September 2024

  1. (diff | hist) 23:53 Nantong Guangyuan Chemical 5,031 +747 KPV_Kester (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) N 17:54 Liquid chromatography-mass spectrometry 1,347 +1,347 MassSpecMarv (talk | contribs) new article: analytical method, expansion welcome
  3. (diff | hist) m 15:42 Retention time 1,620 ±0 GroupBuyGalen (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  4. (diff | hist) m 11:25 Insulin syringe 2,649 +29 KarlFischerKit (talk | contribs) ce, tighten prose [rollback]
  5. (diff | hist) N 06:20 TRIUMPH trial programme 1,217 +1,217 FreightFenna (talk | contribs) create article — trial programme stub
  6. (diff | hist) m 04:55 Electrospray ionisation 1,979 +653 ColumnOvenCoy (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]

17 September 2024

  1. (diff | hist) 23:12 Timeline of incretin therapeutics 2,352 +166 TriumphThad (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) m 21:57 GLP-1 receptor 3,867 +153 ArcuateArt (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  3. (diff | hist) m 20:38 Third-party testing 3,553 +140 ImageReuseIris (talk | contribs) add the turnaround time the service publishes [rollback]
  4. (diff | hist) 14:14 Bacterial endotoxin test 2,127 ±0 AnalyticalAnnie (talk | contribs) split overlong sentence [rollback]
  5. (diff | hist) 11:01 Qingdao Sigma Chemical 2,798 +592 ChainCustodyChad (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  6. (diff | hist) m 10:12 Janoshik Analytical 2,844 ±0 SecondarySrc_Seb (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  7. (diff | hist) 10:08 Solid-phase peptide synthesis 2,718 +108 ForestPlotFinn (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  8. (diff | hist) N 09:00 Arcuate nucleus 1,271 +1,271 MetricMabel (talk | contribs) new article: incretin physiology, expansion welcome
  9. (diff | hist) N 09:00 Blind sampling 2,941 +2,941 Peptide_Pete (talk | contribs) start article on the testing subject
  10. (diff | hist) m 06:08 Dual incretin agonist 3,231 +40 ReportReaderRilla (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  11. (diff | hist) m 04:34 Weight regain after discontinuation 1,814 ±0 BiliaryBea (talk | contribs) add the perioperative consideration with the society guidance it comes from [rollback]
  12. (diff | hist) m 01:25 Reference standard 2,872 ±0 ColdChainCleo (talk | contribs) ce [rollback]

16 September 2024

  1. (diff | hist) 23:49 GL Biochem (Shanghai) 6,391 +1,072 ShortageShona (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  2. (diff | hist) 20:48 Lyophilisation 4,024 ±0 ColdChainCleo (talk | contribs) rm a duplicated category [rollback]
  3. (diff | hist) 19:35 Wuhan Wansheng Biotechnology 5,540 +344 BatchNumberBede (talk | contribs) copyedit [rollback]
  4. (diff | hist) 19:06 SURMOUNT trial programme 2,567 +31 Retention_Time_Rae (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  5. (diff | hist) 18:27 Guangzhou JEEP Biotechnology 4,637 +33 ReportReaderRilla (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  6. (diff | hist) 03:39 Adverse effects of GLP-1 receptor agonists 3,137 ±0 DulaglutideDug (talk | contribs) correct the severity grading scale named [rollback]
  7. (diff | hist) 02:37 Fmoc chemistry 2,652 ±0 SafetySignalSid (talk | contribs) add the collapse-temperature point, sourced [rollback]

15 September 2024

  1. (diff | hist) m 20:53 Lot traceability 2,212 +36 OralSemaOswin (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 17:34 Peptide content 1,955 +682 AnalyticalAnnie (talk | contribs) clarify that area percent is not mass percent [rollback]
  3. (diff | hist) m 12:22 Peptide synthesis 2,919 +121 CDMO_Caradoc (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 11:32 Vial 7,798 +1,039 FreightFenna (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  5. (diff | hist) 08:42 Bacteriostatic water 2,807 ±0 UnitsUrsula (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  6. (diff | hist) m b 08:10 Liraglutide 2,493 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]